BioPharm Asia (NASDAQOTCBB:BFAR.OB)

CAPS Rating 1 out of 5 
BFAR.OB VS S&P 500 (SPY)

This ticker is not currently Ratable.

Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPS

All Players

4 Outperform
10 Underperform
 

All-Star Players

1 Outperform
3 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

BFAR.OB Summary

Top BFAR.OB Bull/Bear Pitches

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

TSIF (99.95)
Submitted May 18, 2010

BioPharm Asia is a fairly new (1 year) US uplist that started about $5.00 per share, but spent the last few months around $1, before rising back up above $4 this week on two events. One good earning and filing of "late" SEC reports that gave it the… More

Featured Broker Partners


Advertisement